# 3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erythematosus Study Protocol 2

> **NCT05747651** · — · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Brest** · enrollment: 10 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus (SLE)

## Interventions

- **BIOLOGICAL:** Blood sample
- **BIOLOGICAL:** Urine sample
- **BIOLOGICAL:** Saliva sample
- **BIOLOGICAL:** Stool sample
- **BIOLOGICAL:** Tissue sample

## Key facts

- **NCT ID:** NCT05747651
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-03-27
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05747651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05747651, "3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erythematosus Study Protocol 2". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05747651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*